SK Life Science Labs
Xuqing Zhang is a Senior Director of Discovery Chemistry at SK Life Science Labs, a position held since October 2023, focusing on utilizing the ubiquitin-protease system for developing transformative medicines. Prior to this, Xuqing Zhang served as Senior Director of Medicinal Chemistry at Proteovant Therapeutics from April 2021 to October 2023, where responsibilities included advancing disease-modifying therapies through novel protein degrader programs. Xuqing Zhang's extensive experience includes 21 years at The Janssen Pharmaceutical Companies of Johnson & Johnson, progressing from Scientist to Senior Principal Scientist. Academic qualifications comprise a PhD in Organic Chemistry from Rensselaer Polytechnic Institute, an MS in Organic Chemistry from the Chinese Academy of Sciences, and a BS in Polymer Science from Fudan University.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU